<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">inovmed</journal-id><journal-title-group><journal-title xml:lang="ru">Инновационная медицина Кубани</journal-title><trans-title-group xml:lang="en"><trans-title>Innovative Medicine of Kuban</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2541-9897</issn><publisher><publisher-name>Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 1</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.35401/2541-9897-2023-26-3-54-61</article-id><article-id custom-type="elpub" pub-id-type="custom">inovmed-719</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Бужирование инфаркт связанной коронарной артерии как метод снижения частоты встречаемости феномена no-reflow у пациентов с острым коронарным синдромом с подъемом сегмента ST</article-title><trans-title-group xml:lang="en"><trans-title>Dilation of the Infarct-Related Coronary Artery to Reduce the Incidence of the No-Reflow Phenomenon in STEMI Patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0277-1880</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сазанов</surname><given-names>Г. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sazanov</surname><given-names>G. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Григорий Вячеславович Сазанов, врач по рентгенэндоваскулярной диагностике и лечению</p><p>отделение рентгенохирургических методов диагностики и лечения</p><p>355000</p><p>ул. Семашко 1</p><p>Ставрополь</p></bio><bio xml:lang="en"><p>Grigoriy V. Sazanov, Interventional Radiologist</p><p>Division of Image-Guided Diagnosis and Surgery</p><p>355000</p><p>ulitsa Semashko 1</p><p>Stavropol</p></bio><email xlink:type="simple">mc_sagr@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5335-5062</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шугушев</surname><given-names>З. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Shugushev</surname><given-names>Z. Kh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Заурбек Хасанович Шугушев, д. м. н., профессор, заведующий кафедрой</p><p>кафедра сердечно-сосудистой хирургии факультета непрерывного медицинского образования</p><p>Москва</p></bio><bio xml:lang="en"><p>Zaurbek Kh. Shugushev, Dr. Sci. (Med.), Professor, Head of the Department</p><p>Cardiovascular Surgery Department, Faculty of Continuous</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5794-1085</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белоконь</surname><given-names>О. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Belokon</surname><given-names>O. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Олег Сергеевич Белоконь, к. м. н., заведующий отделением</p><p>отделение рентгенохирургических методов диагностики и лечения</p><p>Ставрополь</p></bio><bio xml:lang="en"><p>Oleg S. Belokon, Cand. Sci. (Med.), Head of the Division</p><p>Division of Image-Guided Diagnosis and Surgery</p><p>Stavropol</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5679-1775</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ермаков</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ermakov</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сергей Васильевич Ермаков, к. м. н., врач-невролог, врач по рентгенэндоваскулярной диагностике и лечению</p><p>нейрохирургическое отделение № 1</p><p>отделение рентгенохирургических методов диагностики и лечения</p><p>Ставрополь</p></bio><bio xml:lang="en"><p>Sergey V. Ermakov, Cand. Sci. (Med.), Neurologist, Interventional Radiologist</p><p>Neurosurgery Unit No. 1</p><p>Division of Image-Guided Diagnosis and Surgery</p><p>Stavropol</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8734-4188</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хрипунова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Khripunova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алеся Александровна Хрипунова, доцент</p><p>кафедра общественного здоровья и здравоохранения, медицинской профилактики и информатики</p><p>Ставрополь</p></bio><bio xml:lang="en"><p>Alesya A. Khripunova, Associate Professor</p><p>Department of Public Health and Health Care, Preventive Health Care andHealth Informatics</p><p>Stavropol</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ставропольская краевая клиническая больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Stavropol Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Российский университет дружбы народов им. Патриса Лумумбы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Patrice Lumumba Peoples’ Friendship University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Ставропольский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Stavropol State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>30</day><month>09</month><year>2023</year></pub-date><volume>0</volume><issue>3</issue><fpage>54</fpage><lpage>61</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сазанов Г.В., Шугушев З.Х., Белоконь О.С., Ермаков С.В., Хрипунова А.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Сазанов Г.В., Шугушев З.Х., Белоконь О.С., Ермаков С.В., Хрипунова А.А.</copyright-holder><copyright-holder xml:lang="en">Sazanov G.V., Shugushev Z.K., Belokon O.S., Ermakov S.V., Khripunova A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.innovmedkub.ru/jour/article/view/719">https://www.innovmedkub.ru/jour/article/view/719</self-uri><abstract><sec><title>   Актуальность</title><p>   Актуальность: Патогенез феноменов slow/no-reflow является важнейшей медико-социальной проблемой, ввиду высоких показателей летальности и утраты трудоспособности у пациентов с острым коронарным синдромом с подъемом сегмента ST (ОКСпST). Феномены slow/no-reflow являются многофакторными патогенетическими процессами, включающими 4 основных звена: 1) дистальную эмболию коронарного русла в бассейне инфаркт-связанной коронарной артерии (ИСКА); 2) ишемическое повреждение миокарда; 3) реперфузионное поражение сердечной мышцы; 4) индивидуальную (генетическую) предрасположенность к поражению микроциркуляторного русла.</p></sec><sec><title>   Цель исследования</title><p>   Цель исследования: Анализ исходов чрескожного коронарного вмешательства у пациентов c ОКСпST и кровотоком по шкале thrombolysis in myocardial infarction (TIMI) 0 в ИСКА, в зависимости от стратегии восстановления антеградного кровотока (баллонной предилатации или бужирования ИСКА).</p></sec><sec><title>   Материалы и методы</title><p>   Материалы и методы: Выполнен анализ результатов лечения 209 пациентов с ОКСпST и кровотоком TIMI 0. В зависимости от стратегии чрезкожного коронарного вмешательства больные были распределены на 2 группы: в 1-ю группу вошли 147 пациентов, которым с целью восстановления антеградного кровотока выполнялась баллонная ангиопластика, во 2-ю группу – 62 пациента, которым проведено бужирование ИСКА.</p></sec><sec><title>   Результаты</title><p>   Результаты: В ходе исследования установлено, что выполнение прямого стентирования у пациентов с ОКСпST характеризовалось статистически значимо более низким риском возникновения феноменов slow- и no-reflow (p = 0,001, Хи-квадрат Пирсона) и, как следствие, лучшими функциональными исходами лечения больных (степень хронической сердечной недостаточности по Н. Д. Стражеско, В. Х. Василенко и фракции выброса левого желудочка), которые также были статистически значимы (p = 0,001, Хи-квадрат Пирсона).</p></sec><sec><title>   Заключение</title><p>   Заключение: Риск возникновения феноменов slow/no-reflow у пациентов с кровотоком TIMI 0 ИСКА статистически значимо ниже (p = 0,001, Хи-квадрат Пирсона) в группе пациентов, которым для восстановления антеградного кровотока выполнено бужирование ИСКА, функциональные исходы лечения (степень хронической сердечной недостаточности, общая выживаемость) были также лучше у больных, которым было выполнено бужирование ИСКА (p = 0,001, Хи-квадрат Пирсона). Кроме того, бужирование ИСКА было ассоциировано с сохранением фракции выброса левого желудочка в сравнении с группой пациентов, которым для восстановления антеградного кровотока применялась баллонная ангиопластика (p &lt; 0,001, Хи-квадрат Пирсона).</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>   Background</title><p>   Background: The pathogenesis of slow/no-reflow phenomena is a critical socio-medical problem due to high mortality and work disability rates in patients with ST-segment elevation myocardial infarction (STEMI). Slow/no-reflow phenomena are multifactorial involving 4 key elements: 1) distal embolization of the coronary bed of the infarct-related coronary artery; 2) ischemic damage to the myocardium; 3) reperfusion injury of the heart muscle; 4) individual (genetic) susceptibility of the microcirculation to injury.</p></sec><sec><title>   Objective</title><p>   Objective: To analyze the outcomes of percutaneous coronary interventions (PCI) in patients with STEMI and TIMI 0 blood flow of an infarct-related coronary artery based on the strategy to restore antegrade blood flow (balloon predilation or dilation of an infarctrelated artery).</p></sec><sec><title>   Materials and methods</title><p>   Materials and methods: We analyzed treatment outcomes of 209 patients with STEMI and TIMI 0 blood flow. The patients were grouped based on the PCI strategy: group 1 included 147 patients who underwent balloon angioplasty to restore antegrade blood flow, and group 2 included 62 patients who underwent dilation of an infarct-related coronary artery.</p></sec><sec><title>   Results</title><p>   Results: Our study found that direct stenting in STEMI patients was associated with statistically significantly lower risk of slow/noreflow phenomena (P = 0.001, Pearson’s χ2) and, as a result, better functional outcomes of treatment (chronic heart failure grade classified according to Strazhesko-Vasilenko and by left ventricular ejection fraction) that were also statistically significant (P = 0.001, Pearson’s χ2).</p></sec><sec><title>   Conclusions</title><p>   Conclusions: Our study demonstrated that the risk of slow/no-reflow phenomena in patients with TIMI 0 blood flow of an infarctrelated coronary artery was statistically significantly lower (P = .001, Pearson’s χ2) in the group of patients who underwent dilation of an infarct-related coronary artery to restore antegrade blood flow. Functional outcomes (chronic heart failure grade and overall survival) were also better in this group of patients (P = .001, Pearson’s Chi-square). Moreover, dilation of an infarct-related coronary artery was associated with preserved left ventricular ejection fraction compared with the group of patients who underwent balloon angioplasty to restore antegrade blood flow (P &lt; 0.001, Pearson’s χ2).</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>острый коронарный синдром с подъемом сегмента ST</kwd><kwd>чрескожные коронарные вмешательства</kwd><kwd>феномен no-reflow/slow-reflow</kwd><kwd>бужирование коронарных артерий</kwd></kwd-group><kwd-group xml:lang="en"><kwd>STEMI</kwd><kwd>percutaneous coronary interventions</kwd><kwd>no-reflow/slow-reflow phenomenon</kwd><kwd>coronary artery dilation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Под ред. Алекяна Б.Г. Рентгенэндоваскулярная хирургия. Национальное руководство: в 4 т. Т. 2. Ишемическая болезнь сердца. Литтерра; 2017:399–426.</mixed-citation><mixed-citation xml:lang="en">Alekyan BG, ed. Endovascular Surgery. Textbook: Four-Volume Edition. Vol 2. Ischemic Heart Disease. Litterra; 2017:399–426. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Сазанов Г.В., Белоконь О.С. Влияние предилатации на частоту возникновения феномена no/slow-reflow у пациентов с острым коронарным синдромом с подъемом сегмента ST. Казанский медицинский журнал. 2020;101(2):284–288. doi: 10.17816/KMJ2020-284</mixed-citation><mixed-citation xml:lang="en">Sazanov GV, Belokon’ OS. The effect of predilation on the incidence of the no/slow-reflow phenomenon in patients with acute coronary syndrome with ST segment elevation. Kazan Medical Journal. 2020;101(2):284–288. (In Russ.). doi: 10.17816/KMJ2020-284</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ma M, Wang L, Diao KY, et al. A randomized controlled clinical trial of prolonged balloon inflation during stent deployment strategy in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a pilot study. BMC Cardiovasc Disord. 2022;22(1):30. PMID: 35120436. PMCID: PMC8815170. doi: 10.1186/s12872-022-02477-0</mixed-citation><mixed-citation xml:lang="en">Ma M, Wang L, Diao KY, et al. A randomized controlled clinical trial of prolonged balloon inflation during stent deployment strategy in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a pilot study. BMC Cardiovasc Disord. 2022;22(1):30. PMID: 35120436. PMCID: PMC8815170. doi: 10.1186/s12872-022-02477-0</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Montone RA, Camilli M, Del Buono MG, et al. No-reflow: update on diagnosis, pathophysiology and therapeutic strategies. G Ital Cardiol (Rome). 2020;21(6 suppl 1):4S–14S. (In Italian). PMID: 32469339. doi: 10.1714/3373.33487</mixed-citation><mixed-citation xml:lang="en">Montone RA, Camilli M, Del Buono MG, et al. No-reflow: update on diagnosis, pathophysiology and therapeutic strategies. G Ital Cardiol (Rome). 2020;21(6 suppl 1):4S–14S. (In Italian). PMID: 32469339. doi: 10.1714/3373.33487</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Исхаков М.М., Тагирова Д.Р., Газизов Н.В., Нугайбекова Л.А., Сайфутдинов Р.Г. Феномен “no-reflow”: клинические аспекты неудачи реперфузии. Казанский медицинский журнал. 2015;96(3):391–396. doi: 10.17750/KMJ2015-391</mixed-citation><mixed-citation xml:lang="en">Iskhakov MM, Tagirova DR, Gazizov NV, Nugaybekova LA, Sayfutdinov RG. «No-reflow» phenomenon: clinical aspects of reperfusion failure. Kazan Medical Journal. 2015;96(3):391–396. (In Russ.). doi: 10.17750/KMJ2015-391</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Yaméogo NV, Guenancia C, Porot G, et al. Predictors of angiographically visible distal embolization in STEMI. Herz. 2020;45(3):288–292. PMID: 29926119. doi: 10.1007/s00059-018-4723-1.</mixed-citation><mixed-citation xml:lang="en">Yaméogo NV, Guenancia C, Porot G, et al. Predictors of angiographically visible distal embolization in STEMI. Herz. 2020;45(3):288–292. PMID: 29926119. doi: 10.1007/s00059-018-4723-1.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Heusch G, Skyschally A, Kleinbongard P. Coronary microembolization and microvascular dysfunction. Int J Cardiol. 2018;258:17–23. PMID: 29429637. doi: 10.1016/j.ijcard.2018.02.010</mixed-citation><mixed-citation xml:lang="en">Heusch G, Skyschally A, Kleinbongard P. Coronary microembolization and microvascular dysfunction. Int J Cardiol. 2018;258:17–23. PMID: 29429637. doi: 10.1016/j.ijcard.2018.02.010</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Журавлев А.С., Азаров А.В., Семитко С.П., Иоселиани Д.Г. Феномен no-reflow во время первичного чрескожного коронарного вмешательства у пациентов с острым инфарктом миокарда с подъемом сегмента ST, обусловленным массивным коронарным тромбозом. Патогенез и предикторы no-reflow. Кардиология. 2021;61(2): 99–105. doi: 10.18087/cardio.2021.2.n1175</mixed-citation><mixed-citation xml:lang="en">Zhuravlev AS, Azarov AV, Semitko SP, Ioseliani DG. The noreflow phenomenon during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction due to massive coronary thrombosis. Pathogenesis and predictors of no-reflow. Kardiologiia. 2021;61(2):99–105. (In Russ.). doi: 10.18087/cardio.2021.2.n1175</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Claeys MJ, Bosmans J, De Ceuninck M, et al. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction. Am J Cardiol. 2004;94(1):9–13. PMID: 15219500. doi: 10.1016/j.amjcard.2004.03.021</mixed-citation><mixed-citation xml:lang="en">Claeys MJ, Bosmans J, De Ceuninck M, et al. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction. Am J Cardiol. 2004;94(1):9–13. PMID: 15219500. doi: 10.1016/j.amjcard.2004.03.021</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou H, He XY, Zhuang SW, et al. Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention. World J Emerg Med. 2014;5(2):96–102. PMID: 25215156. PMCID: PMC4129879. doi: 10.5847/wjem.j.issn.1920-8642.2014.02.003</mixed-citation><mixed-citation xml:lang="en">Zhou H, He XY, Zhuang SW, et al. Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention. World J Emerg Med. 2014;5(2):96–102. PMID: 25215156. PMCID: PMC4129879. doi: 10.5847/wjem.j.issn.1920-8642.2014.02.003</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Reffelmann T, Kloner RA. The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol. 2006;101(5):359–372. PMID: 16915531. doi: 10.1007/s00395-006-0615-2</mixed-citation><mixed-citation xml:lang="en">Reffelmann T, Kloner RA. The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol. 2006;101(5):359–372. PMID: 16915531. doi: 10.1007/s00395-006-0615-2</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wu MY, Yiang GT, Liao WT, et al. Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 2018;46(4):1650–1667. PMID: 29694958. doi: 10.1159/000489241</mixed-citation><mixed-citation xml:lang="en">Wu MY, Yiang GT, Liao WT, et al. Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 2018;46(4):1650–1667. PMID: 29694958. doi: 10.1159/000489241</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J, Toan S, Zhou H. New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis. 2020;23(3):299–314. PMID: 32246225. doi: 10.1007/s10456-020-09720-2</mixed-citation><mixed-citation xml:lang="en">Wang J, Toan S, Zhou H. New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis. 2020;23(3):299–314. PMID: 32246225. doi: 10.1007/s10456-020-09720-2</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Palmer A, Lupu L, Huber-Lang M. Inflammatory response to the ischaemia-reperfusion insult in the liver after major tissue trauma. Eur J Trauma Emerg Surg. 2022;48(6):4431–4444. PMID: 35831749. PMCID: PMC9712415. doi: 10.1007/s00068-022-02026-6</mixed-citation><mixed-citation xml:lang="en">Li Y, Palmer A, Lupu L, Huber-Lang M. Inflammatory response to the ischaemia-reperfusion insult in the liver after major tissue trauma. Eur J Trauma Emerg Surg. 2022;48(6):4431–4444. PMID: 35831749. PMCID: PMC9712415. doi: 10.1007/s00068-022-02026-6</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yalcin Y, Biyik I, Akturk E, et al. Association between endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and coronary no-reflow phenomenon in acute myocardial infarction. Advances in Hygiene and Experimental Medicine. 2019;73:529–535. doi: 10.5604/01.3001.0013.5253</mixed-citation><mixed-citation xml:lang="en">Yalcin Y, Biyik I, Akturk E, et al. Association between endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and coronary no-reflow phenomenon in acute myocardial infarction. Advances in Hygiene and Experimental Medicine. 2019;73:529–535. doi: 10.5604/01.3001.0013.5253</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ashoori A, Pourhosseini H, Ghodsi S, et al. CHA2DS2-VASc score as an independent predictor of suboptimal reperfusion and short-term mortality after primary PCI in patients with acute ST segment elevation myocardial infarction. Medicina (Kaunas). 2019;55(2):35. PMID: 30717292. PMCID: PMC6409514. doi: 10.3390/medicina55020035</mixed-citation><mixed-citation xml:lang="en">Ashoori A, Pourhosseini H, Ghodsi S, et al. CHA2DS2-VASc score as an independent predictor of suboptimal reperfusion and short-term mortality after primary PCI in patients with acute ST segment elevation myocardial infarction. Medicina (Kaunas). 2019;55(2):35. PMID: 30717292. PMCID: PMC6409514. doi: 10.3390/medicina55020035</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ipek G, Onuk T, Karatas MB, et al. CHA2DS2-VASc score is a predictor of no-reflow in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous intervention. Angiology. 2016;67(9):840–845. (In English, Spanish). PMID: 26685178. doi: 10.1177/0003319715622844</mixed-citation><mixed-citation xml:lang="en">Ipek G, Onuk T, Karatas MB, et al. CHA2DS2-VASc score is a predictor of no-reflow in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous intervention. Angiology. 2016;67(9):840–845. (In English, Spanish). PMID: 26685178. doi: 10.1177/0003319715622844</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mirbolouk F, Gholipour M, Salari A, et al. CHA2DS2-VASc score predict no-reflow phenomenon in primary percutaneous coronary intervention in primary percutaneous coronary intervention. J Cardiovasc Thorac Res. 2018;10(1):46–52. PMID: 29707178. PMCID: PMC5913693. doi: 10.15171/jcvtr.2018.08</mixed-citation><mixed-citation xml:lang="en">Mirbolouk F, Gholipour M, Salari A, et al. CHA2DS2-VASc score predict no-reflow phenomenon in primary percutaneous coronary intervention in primary percutaneous coronary intervention. J Cardiovasc Thorac Res. 2018;10(1):46–52. PMID: 29707178. PMCID: PMC5913693. doi: 10.15171/jcvtr.2018.08</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Namazi M, Mahmoudi E, Safi E, et al. The no-reflow phenomenon: is it predictable by demographic factors and routine laboratory data?. Acta Biomed. 2021;92(5):e2021297. PMID: 34738591. PMCID: PMC8689329 doi: 10.23750/abm.v92i5.10053</mixed-citation><mixed-citation xml:lang="en">Namazi M, Mahmoudi E, Safi E, et al. The no-reflow phenomenon: is it predictable by demographic factors and routine laboratory data?. Acta Biomed. 2021;92(5):e2021297. PMID: 34738591. PMCID: PMC8689329 doi: 10.23750/abm.v92i5.10053</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kim BG, Cho SW, Seo J, et al. Effect of direct stenting on microvascular dysfunction during percutaneous coronary intervention in acute myocardial infarction: a randomized pilot study. J Int Med Res. 2022;50(9):1–9. PMID: 36177850. PMCID: PMC9528029. doi: 10.1177/03000605221127888</mixed-citation><mixed-citation xml:lang="en">Kim BG, Cho SW, Seo J, et al. Effect of direct stenting on microvascular dysfunction during percutaneous coronary intervention in acute myocardial infarction: a randomized pilot study. J Int Med Res. 2022;50(9):1–9. PMID: 36177850. PMCID: PMC9528029. doi: 10.1177/03000605221127888</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
